The disclosure describes jasmonate conjugates and nanocarried and/or microcarried jasmonate conjugates and pharmaceutical compositions thereof as well as use thereof for treating or preventing angiogenesis related or NF B related disorders. Also disclosed are methods of making the conjugates.